GSK Consumer Healthcare's CEO Brian McNamara said he had not seen signs that the cost of living crisis was impacting consumer purchases, with sales at the business up 16% in Q1.
GlaxoSmithKline Consumer Healthcare looks to be in good shape ahead of its transition to standalone company Haleon in July. The business posted Q1 sales up by 14% – 16% at constant currencies and excluding the impact of divested brands – to £2.63bn ($3.29bn) as its cold and flu brands rebounded from an historically low level in the prior-year period.
Operating profit jumped by 21%, lifting the margin to 24.7%. A combination of volume growth and price increases – as...
In a major milestone for the EU’s pricing and reimbursement landscape, the European Commission has published the first ever, much anticipated, joint clinical assessment report.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Weak demand for virus-blocking nasal sprays since the pandemic has left Austrian biotech Marinomed with mounting debts. The company has applied for restructuring proceedings with an Austrian court in an attempt to secure its future.
Perrigo aims its new SolpaOne high-strength paracetamol effervescent at UK pharmacists, who now have expanded powers as part of the UK government's Pharmacy First initiative.
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.
